Intranasal esketamine for treatment-resistant depression in real-world clinical practice

Neuroscience Applied 2026 Open access

Read full text
Authors: A.A. Porras-Segovia, AM de Granda-Beltrán, I. Conejero, E. Baca-García
DOI: 10.1016/j.nsa.2025.105948
Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Anxiety Depression Psychometrics Treatment Cognitive Processes

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
105948–105948
Publication date
1 January 2026
Language
EN